This transcriptomic and genomic analysis of PFESA-BP2 exposure reveals the PFESA-BP2-induced dose-dependent dysregulation of key genes and pathways, specifically those related to hepatotoxicity and hepatocellular carcinoma (HCC). This evidence concerns the gene IGFBP2 and hepatocellular carcinoma.